Latest Research, Industry, Medical and Scientific News

microbiologist at laboratory work

BioLife Products Embedded in Cook MyoSite Phase 3 Cell Therapy Trial for Stress Urinary Incontinence

BioLife Solutions, Inc.(BioLife, a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, announced that its media products are embedded into the autologous cell therapy being developed by Pittsburgh-based Cook MyoSite, a subsidiary of the Cook Group, for treatment of female stress urinary incontinence.  Read more.

Source: PharmaBiz.com, July 19, 2016

PeriCoach

FDA Approves OTC Availability of PeriCoach, an At-home Pelvic Floor Trainer Device

DENVER – Analytica on Wednesday announced that the U.S. Food and Drug Administration has approved the PeriCoach at-home pelvic floor trainer device and smartphone app as an over-the-counter treatment for mild, moderate and stress urinary incontinence and urge incontinence.  Pelvic floor muscle exercise is recommended as first line non-pharmacologic treatment for the millions of women – estimated at one in three – who suffer from urinary incontinence.  Read more.

Source: Drug Store News, July 13, 2016

Domtar Expands Personal Care Portfolio with Purchase of Butterfly Health Inc.

Every day, Domtar improves the quality of peoples’ lives by providing dignity and choice through its Personal Care products. In line with its strategy and core capabilities, Domtar Corporation (NYSE: UFS) (TSX: UFS) has purchased the assets of Butterfly Health Inc. BUTTERFLY® body liners offer discreet, secure protection for accidental bowel leakage (ABL). “This product provides a unique solution to a problem that exists for roughly 1 out of 10 people. It represents a complementary addition to our portfolio of brands and technologies,” stated Mike Fagan, President of Domtar Personal Care. Read more.

Source: Business Wire, June 27, 2016

product approval

Axonics Sacral Neuromodulation System for Urinary and Fecal Dysfunctions

Axonics Modulation Technologies won European regulatory approval for its Sacral Neuromodulation System (SNM), a product designed to treat overactive bladder, urinary retention, and fecal incontinence.  The device is rechargeable, and so can be used for longer periods than similar devices that have to be replaced with new batteries periodically.  Read more.

Source: Medgadget, June 7, 2016